SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-006502
Filing Date
2011-02-02
Accepted
2011-02-02 18:01:24
Documents
1
Period of Report
2011-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12010
  Complete submission text file 0001209191-11-006502.txt   13733
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Issuer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 4 TUCKERS TOWN ROAD ST. GEORGE'S PARISH D0 HS02
Business Address
GREETHAM ELIZABETH M (Reporting) CIK: 0001206367 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15875 | Film No.: 11567822